7 studies found for:    F2695
Show Display Options
Rank Status Study
1 Completed Safety Study of F2695 SR in Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: F2695 SR
2 Completed Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Conditions: Depression;   Major Depressive Disorder
Interventions: Drug: F2695 SR;   Drug: Placebo
3 Completed Safety and Efficacy of F2695 SR in Adults With Fatigue Associated With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: F2695 SR;   Drug: Paroxetine, Sertraline, or Fluoxetine;   Drug: Placebo
4 Recruiting Effect of F2695 on Functional Recovery After Ischemic Stroke
Condition: Ischemic Stroke
Interventions: Drug: F2695;   Drug: placebo
5 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
6 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo
7 Completed
Has Results
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Levomilnacipran ER;   Drug: Placebo

Indicates status has not been verified in more than two years